Form 4 for BSX Boston Scientific
Accepted 2023-11-21 00:00:00 ET · period of report 2023-11-20 · accession 0001225208-23-010345 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-21 | 2023-11-20 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $17.26 | +3,859 | 15.3K | +34% | +$66.6K |
| D | 2023-11-21 | 2023-11-20 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $54.06 | -8,278 | 6,977 | -54% | -$447.5K |
| D | 2023-11-21 | 2023-11-20 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | -3,859 | 8,072 | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-20 | M | A | 3,859 | $17.26 | 15,255 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-20 | S | D | 8,278 | $54.06 | 6,977 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-11-20 | M | D | 3,859 | $0.00 | 8,072 | D | $17.26 · — to 2026-02-22 | 3,859 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |